Prof. Lars Steinmetz is a leading scientist at the forefront of genomics research and technology development. He obtained his undergraduate degree from Yale University and a PhD from Stanford University in 2001. At the age of 27 he started his own research group at the European Molecular Biology Laboratory (EMBL) and at Stanford University, with the aim to dissect the molecular events that lead from genotype to phenotype.
Since 2013, Dr. Steinmetz splits his time equally between EMBL and Stanford University, where he is Professor of Genetics at the School of Medicine and Co-Director of the Stanford Genome Technology Center. Dr. Steinmetz’s fundamental discoveries have given insights into the genetic basis of complex traits ranging from model systems to humans. Many of the technologies he pioneered have since become gold-standards that are widely applied by others. In addition to his academic endeavours, Dr. Steinmetz is a consultant and board member of several companies, advising in the areas of genetics and personalised medicine. Within the Grace Science Foundation, Dr. Steinmetz is developing and applying systems biology approaches to find a cure for NGLY1 Deficiency and benefit the patients.